Global Nano Antibodies Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Nano Antibodies market size was valued at US$ 279.4 million in 2023. With growing demand in downstream market, the Nano Antibodies is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 26.3% during review period.
The research report highlights the growth potential of the global Nano Antibodies market. Nano Antibodies are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nano Antibodies. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nano Antibodies market.
Nanoantibodies or "nAb" are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages:
Small size (~15kd)
High affinity (frequently nanomolar range)
High specificity
Unsurpassed stability
?????????????????????????????????????????????????????
Key Features:
The report on Nano Antibodies market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nano Antibodies market. It may include historical data, market segmentation by Type (e.g., Monovalent Nanobody, Multivalent and multispecific Nanobodies), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nano Antibodies market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nano Antibodies market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nano Antibodies industry. This include advancements in Nano Antibodies technology, Nano Antibodies new entrants, Nano Antibodies new investment, and other innovations that are shaping the future of Nano Antibodies.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nano Antibodies market. It includes factors influencing customer ' purchasing decisions, preferences for Nano Antibodies product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nano Antibodies market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nano Antibodies market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nano Antibodies market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nano Antibodies industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nano Antibodies market.
Market Segmentation:
Nano Antibodies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Nano Antibodies market size was valued at US$ 279.4 million in 2023. With growing demand in downstream market, the Nano Antibodies is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 26.3% during review period.
The research report highlights the growth potential of the global Nano Antibodies market. Nano Antibodies are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nano Antibodies. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nano Antibodies market.
Nanoantibodies or "nAb" are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages:
Small size (~15kd)
High affinity (frequently nanomolar range)
High specificity
Unsurpassed stability
?????????????????????????????????????????????????????
Key Features:
The report on Nano Antibodies market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nano Antibodies market. It may include historical data, market segmentation by Type (e.g., Monovalent Nanobody, Multivalent and multispecific Nanobodies), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nano Antibodies market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nano Antibodies market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nano Antibodies industry. This include advancements in Nano Antibodies technology, Nano Antibodies new entrants, Nano Antibodies new investment, and other innovations that are shaping the future of Nano Antibodies.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nano Antibodies market. It includes factors influencing customer ' purchasing decisions, preferences for Nano Antibodies product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nano Antibodies market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nano Antibodies market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nano Antibodies market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nano Antibodies industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nano Antibodies market.
Market Segmentation:
Nano Antibodies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Monovalent Nanobody
- Multivalent and multispecific Nanobodies
- Fusion Nanobody
- Disease detection in vitro
- Non-invasive diagnosis in vivo
- Tumor targeted therapy
- Nervous system disease
- Circulatory disease
- Infectious disease
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck KGaA
- Sanofi (Ablynx)
- Alphamab Oncology
- Novartis AG
- Genscript
- Taisho Pharmaceutical Holdings
- Sensei Biotherapeutics, Inc.
- Cusabio Technology LLC.
- ChromoTek GmbH
- Beroni Group
- ExeVir Bio BV
- Absolute Antibody
- Alpalife (Shenzhen kangti Co., Ltd.)
- DiosCURE Therapeutics SE
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc. (BioLegend, Inc.)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nano Antibodies Market Size 2019-2030
2.1.2 Nano Antibodies Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nano Antibodies Segment by Type
2.2.1 Monovalent Nanobody
2.2.2 Multivalent and multispecific Nanobodies
2.2.3 Fusion Nanobody
2.3 Nano Antibodies Market Size by Type
2.3.1 Nano Antibodies Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nano Antibodies Market Size Market Share by Type (2019-2024)
2.4 Nano Antibodies Segment by Application
2.4.1 Disease detection in vitro
2.4.2 Non-invasive diagnosis in vivo
2.4.3 Tumor targeted therapy
2.4.4 Nervous system disease
2.4.5 Circulatory disease
2.4.6 Infectious disease
2.4.7 Other
2.5 Nano Antibodies Market Size by Application
2.5.1 Nano Antibodies Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nano Antibodies Market Size Market Share by Application (2019-2024)
3 NANO ANTIBODIES MARKET SIZE BY PLAYER
3.1 Nano Antibodies Market Size Market Share by Players
3.1.1 Global Nano Antibodies Revenue by Players (2019-2024)
3.1.2 Global Nano Antibodies Revenue Market Share by Players (2019-2024)
3.2 Global Nano Antibodies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NANO ANTIBODIES BY REGIONS
4.1 Nano Antibodies Market Size by Regions (2019-2024)
4.2 Americas Nano Antibodies Market Size Growth (2019-2024)
4.3 APAC Nano Antibodies Market Size Growth (2019-2024)
4.4 Europe Nano Antibodies Market Size Growth (2019-2024)
4.5 Middle East & Africa Nano Antibodies Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Nano Antibodies Market Size by Country (2019-2024)
5.2 Americas Nano Antibodies Market Size by Type (2019-2024)
5.3 Americas Nano Antibodies Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nano Antibodies Market Size by Region (2019-2024)
6.2 APAC Nano Antibodies Market Size by Type (2019-2024)
6.3 APAC Nano Antibodies Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nano Antibodies by Country (2019-2024)
7.2 Europe Nano Antibodies Market Size by Type (2019-2024)
7.3 Europe Nano Antibodies Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nano Antibodies by Region (2019-2024)
8.2 Middle East & Africa Nano Antibodies Market Size by Type (2019-2024)
8.3 Middle East & Africa Nano Antibodies Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NANO ANTIBODIES MARKET FORECAST
10.1 Global Nano Antibodies Forecast by Regions (2025-2030)
10.1.1 Global Nano Antibodies Forecast by Regions (2025-2030)
10.1.2 Americas Nano Antibodies Forecast
10.1.3 APAC Nano Antibodies Forecast
10.1.4 Europe Nano Antibodies Forecast
10.1.5 Middle East & Africa Nano Antibodies Forecast
10.2 Americas Nano Antibodies Forecast by Country (2025-2030)
10.2.1 United States Nano Antibodies Market Forecast
10.2.2 Canada Nano Antibodies Market Forecast
10.2.3 Mexico Nano Antibodies Market Forecast
10.2.4 Brazil Nano Antibodies Market Forecast
10.3 APAC Nano Antibodies Forecast by Region (2025-2030)
10.3.1 China Nano Antibodies Market Forecast
10.3.2 Japan Nano Antibodies Market Forecast
10.3.3 Korea Nano Antibodies Market Forecast
10.3.4 Southeast Asia Nano Antibodies Market Forecast
10.3.5 India Nano Antibodies Market Forecast
10.3.6 Australia Nano Antibodies Market Forecast
10.4 Europe Nano Antibodies Forecast by Country (2025-2030)
10.4.1 Germany Nano Antibodies Market Forecast
10.4.2 France Nano Antibodies Market Forecast
10.4.3 UK Nano Antibodies Market Forecast
10.4.4 Italy Nano Antibodies Market Forecast
10.4.5 Russia Nano Antibodies Market Forecast
10.5 Middle East & Africa Nano Antibodies Forecast by Region (2025-2030)
10.5.1 Egypt Nano Antibodies Market Forecast
10.5.2 South Africa Nano Antibodies Market Forecast
10.5.3 Israel Nano Antibodies Market Forecast
10.5.4 Turkey Nano Antibodies Market Forecast
10.5.5 GCC Countries Nano Antibodies Market Forecast
10.6 Global Nano Antibodies Forecast by Type (2025-2030)
10.7 Global Nano Antibodies Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Merck KGaA
11.1.1 Merck KGaA Company Information
11.1.2 Merck KGaA Nano Antibodies Product Offered
11.1.3 Merck KGaA Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck KGaA Main Business Overview
11.1.5 Merck KGaA Latest Developments
11.2 Sanofi (Ablynx)
11.2.1 Sanofi (Ablynx) Company Information
11.2.2 Sanofi (Ablynx) Nano Antibodies Product Offered
11.2.3 Sanofi (Ablynx) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi (Ablynx) Main Business Overview
11.2.5 Sanofi (Ablynx) Latest Developments
11.3 Alphamab Oncology
11.3.1 Alphamab Oncology Company Information
11.3.2 Alphamab Oncology Nano Antibodies Product Offered
11.3.3 Alphamab Oncology Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Alphamab Oncology Main Business Overview
11.3.5 Alphamab Oncology Latest Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Information
11.4.2 Novartis AG Nano Antibodies Product Offered
11.4.3 Novartis AG Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis AG Main Business Overview
11.4.5 Novartis AG Latest Developments
11.5 Genscript
11.5.1 Genscript Company Information
11.5.2 Genscript Nano Antibodies Product Offered
11.5.3 Genscript Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Genscript Main Business Overview
11.5.5 Genscript Latest Developments
11.6 Taisho Pharmaceutical Holdings
11.6.1 Taisho Pharmaceutical Holdings Company Information
11.6.2 Taisho Pharmaceutical Holdings Nano Antibodies Product Offered
11.6.3 Taisho Pharmaceutical Holdings Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Taisho Pharmaceutical Holdings Main Business Overview
11.6.5 Taisho Pharmaceutical Holdings Latest Developments
11.7 Sensei Biotherapeutics, Inc.
11.7.1 Sensei Biotherapeutics, Inc. Company Information
11.7.2 Sensei Biotherapeutics, Inc. Nano Antibodies Product Offered
11.7.3 Sensei Biotherapeutics, Inc. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sensei Biotherapeutics, Inc. Main Business Overview
11.7.5 Sensei Biotherapeutics, Inc. Latest Developments
11.8 Cusabio Technology LLC.
11.8.1 Cusabio Technology LLC. Company Information
11.8.2 Cusabio Technology LLC. Nano Antibodies Product Offered
11.8.3 Cusabio Technology LLC. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Cusabio Technology LLC. Main Business Overview
11.8.5 Cusabio Technology LLC. Latest Developments
11.9 ChromoTek GmbH
11.9.1 ChromoTek GmbH Company Information
11.9.2 ChromoTek GmbH Nano Antibodies Product Offered
11.9.3 ChromoTek GmbH Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 ChromoTek GmbH Main Business Overview
11.9.5 ChromoTek GmbH Latest Developments
11.10 Beroni Group
11.10.1 Beroni Group Company Information
11.10.2 Beroni Group Nano Antibodies Product Offered
11.10.3 Beroni Group Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Beroni Group Main Business Overview
11.10.5 Beroni Group Latest Developments
11.11 ExeVir Bio BV
11.11.1 ExeVir Bio BV Company Information
11.11.2 ExeVir Bio BV Nano Antibodies Product Offered
11.11.3 ExeVir Bio BV Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 ExeVir Bio BV Main Business Overview
11.11.5 ExeVir Bio BV Latest Developments
11.12 Absolute Antibody
11.12.1 Absolute Antibody Company Information
11.12.2 Absolute Antibody Nano Antibodies Product Offered
11.12.3 Absolute Antibody Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Absolute Antibody Main Business Overview
11.12.5 Absolute Antibody Latest Developments
11.13 Alpalife (Shenzhen kangti Co., Ltd.)
11.13.1 Alpalife (Shenzhen kangti Co., Ltd.) Company Information
11.13.2 Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Product Offered
11.13.3 Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Alpalife (Shenzhen kangti Co., Ltd.) Main Business Overview
11.13.5 Alpalife (Shenzhen kangti Co., Ltd.) Latest Developments
11.14 DiosCURE Therapeutics SE
11.14.1 DiosCURE Therapeutics SE Company Information
11.14.2 DiosCURE Therapeutics SE Nano Antibodies Product Offered
11.14.3 DiosCURE Therapeutics SE Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 DiosCURE Therapeutics SE Main Business Overview
11.14.5 DiosCURE Therapeutics SE Latest Developments
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Information
11.15.2 Thermo Fisher Scientific Inc. Nano Antibodies Product Offered
11.15.3 Thermo Fisher Scientific Inc. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Thermo Fisher Scientific Inc. Main Business Overview
11.15.5 Thermo Fisher Scientific Inc. Latest Developments
11.16 PerkinElmer Inc. (BioLegend, Inc.)
11.16.1 PerkinElmer Inc. (BioLegend, Inc.) Company Information
11.16.2 PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Product Offered
11.16.3 PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 PerkinElmer Inc. (BioLegend, Inc.) Main Business Overview
11.16.5 PerkinElmer Inc. (BioLegend, Inc.) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nano Antibodies Market Size 2019-2030
2.1.2 Nano Antibodies Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nano Antibodies Segment by Type
2.2.1 Monovalent Nanobody
2.2.2 Multivalent and multispecific Nanobodies
2.2.3 Fusion Nanobody
2.3 Nano Antibodies Market Size by Type
2.3.1 Nano Antibodies Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nano Antibodies Market Size Market Share by Type (2019-2024)
2.4 Nano Antibodies Segment by Application
2.4.1 Disease detection in vitro
2.4.2 Non-invasive diagnosis in vivo
2.4.3 Tumor targeted therapy
2.4.4 Nervous system disease
2.4.5 Circulatory disease
2.4.6 Infectious disease
2.4.7 Other
2.5 Nano Antibodies Market Size by Application
2.5.1 Nano Antibodies Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nano Antibodies Market Size Market Share by Application (2019-2024)
3 NANO ANTIBODIES MARKET SIZE BY PLAYER
3.1 Nano Antibodies Market Size Market Share by Players
3.1.1 Global Nano Antibodies Revenue by Players (2019-2024)
3.1.2 Global Nano Antibodies Revenue Market Share by Players (2019-2024)
3.2 Global Nano Antibodies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NANO ANTIBODIES BY REGIONS
4.1 Nano Antibodies Market Size by Regions (2019-2024)
4.2 Americas Nano Antibodies Market Size Growth (2019-2024)
4.3 APAC Nano Antibodies Market Size Growth (2019-2024)
4.4 Europe Nano Antibodies Market Size Growth (2019-2024)
4.5 Middle East & Africa Nano Antibodies Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Nano Antibodies Market Size by Country (2019-2024)
5.2 Americas Nano Antibodies Market Size by Type (2019-2024)
5.3 Americas Nano Antibodies Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nano Antibodies Market Size by Region (2019-2024)
6.2 APAC Nano Antibodies Market Size by Type (2019-2024)
6.3 APAC Nano Antibodies Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nano Antibodies by Country (2019-2024)
7.2 Europe Nano Antibodies Market Size by Type (2019-2024)
7.3 Europe Nano Antibodies Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nano Antibodies by Region (2019-2024)
8.2 Middle East & Africa Nano Antibodies Market Size by Type (2019-2024)
8.3 Middle East & Africa Nano Antibodies Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NANO ANTIBODIES MARKET FORECAST
10.1 Global Nano Antibodies Forecast by Regions (2025-2030)
10.1.1 Global Nano Antibodies Forecast by Regions (2025-2030)
10.1.2 Americas Nano Antibodies Forecast
10.1.3 APAC Nano Antibodies Forecast
10.1.4 Europe Nano Antibodies Forecast
10.1.5 Middle East & Africa Nano Antibodies Forecast
10.2 Americas Nano Antibodies Forecast by Country (2025-2030)
10.2.1 United States Nano Antibodies Market Forecast
10.2.2 Canada Nano Antibodies Market Forecast
10.2.3 Mexico Nano Antibodies Market Forecast
10.2.4 Brazil Nano Antibodies Market Forecast
10.3 APAC Nano Antibodies Forecast by Region (2025-2030)
10.3.1 China Nano Antibodies Market Forecast
10.3.2 Japan Nano Antibodies Market Forecast
10.3.3 Korea Nano Antibodies Market Forecast
10.3.4 Southeast Asia Nano Antibodies Market Forecast
10.3.5 India Nano Antibodies Market Forecast
10.3.6 Australia Nano Antibodies Market Forecast
10.4 Europe Nano Antibodies Forecast by Country (2025-2030)
10.4.1 Germany Nano Antibodies Market Forecast
10.4.2 France Nano Antibodies Market Forecast
10.4.3 UK Nano Antibodies Market Forecast
10.4.4 Italy Nano Antibodies Market Forecast
10.4.5 Russia Nano Antibodies Market Forecast
10.5 Middle East & Africa Nano Antibodies Forecast by Region (2025-2030)
10.5.1 Egypt Nano Antibodies Market Forecast
10.5.2 South Africa Nano Antibodies Market Forecast
10.5.3 Israel Nano Antibodies Market Forecast
10.5.4 Turkey Nano Antibodies Market Forecast
10.5.5 GCC Countries Nano Antibodies Market Forecast
10.6 Global Nano Antibodies Forecast by Type (2025-2030)
10.7 Global Nano Antibodies Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Merck KGaA
11.1.1 Merck KGaA Company Information
11.1.2 Merck KGaA Nano Antibodies Product Offered
11.1.3 Merck KGaA Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck KGaA Main Business Overview
11.1.5 Merck KGaA Latest Developments
11.2 Sanofi (Ablynx)
11.2.1 Sanofi (Ablynx) Company Information
11.2.2 Sanofi (Ablynx) Nano Antibodies Product Offered
11.2.3 Sanofi (Ablynx) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi (Ablynx) Main Business Overview
11.2.5 Sanofi (Ablynx) Latest Developments
11.3 Alphamab Oncology
11.3.1 Alphamab Oncology Company Information
11.3.2 Alphamab Oncology Nano Antibodies Product Offered
11.3.3 Alphamab Oncology Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Alphamab Oncology Main Business Overview
11.3.5 Alphamab Oncology Latest Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Information
11.4.2 Novartis AG Nano Antibodies Product Offered
11.4.3 Novartis AG Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis AG Main Business Overview
11.4.5 Novartis AG Latest Developments
11.5 Genscript
11.5.1 Genscript Company Information
11.5.2 Genscript Nano Antibodies Product Offered
11.5.3 Genscript Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Genscript Main Business Overview
11.5.5 Genscript Latest Developments
11.6 Taisho Pharmaceutical Holdings
11.6.1 Taisho Pharmaceutical Holdings Company Information
11.6.2 Taisho Pharmaceutical Holdings Nano Antibodies Product Offered
11.6.3 Taisho Pharmaceutical Holdings Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Taisho Pharmaceutical Holdings Main Business Overview
11.6.5 Taisho Pharmaceutical Holdings Latest Developments
11.7 Sensei Biotherapeutics, Inc.
11.7.1 Sensei Biotherapeutics, Inc. Company Information
11.7.2 Sensei Biotherapeutics, Inc. Nano Antibodies Product Offered
11.7.3 Sensei Biotherapeutics, Inc. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sensei Biotherapeutics, Inc. Main Business Overview
11.7.5 Sensei Biotherapeutics, Inc. Latest Developments
11.8 Cusabio Technology LLC.
11.8.1 Cusabio Technology LLC. Company Information
11.8.2 Cusabio Technology LLC. Nano Antibodies Product Offered
11.8.3 Cusabio Technology LLC. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Cusabio Technology LLC. Main Business Overview
11.8.5 Cusabio Technology LLC. Latest Developments
11.9 ChromoTek GmbH
11.9.1 ChromoTek GmbH Company Information
11.9.2 ChromoTek GmbH Nano Antibodies Product Offered
11.9.3 ChromoTek GmbH Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 ChromoTek GmbH Main Business Overview
11.9.5 ChromoTek GmbH Latest Developments
11.10 Beroni Group
11.10.1 Beroni Group Company Information
11.10.2 Beroni Group Nano Antibodies Product Offered
11.10.3 Beroni Group Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Beroni Group Main Business Overview
11.10.5 Beroni Group Latest Developments
11.11 ExeVir Bio BV
11.11.1 ExeVir Bio BV Company Information
11.11.2 ExeVir Bio BV Nano Antibodies Product Offered
11.11.3 ExeVir Bio BV Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 ExeVir Bio BV Main Business Overview
11.11.5 ExeVir Bio BV Latest Developments
11.12 Absolute Antibody
11.12.1 Absolute Antibody Company Information
11.12.2 Absolute Antibody Nano Antibodies Product Offered
11.12.3 Absolute Antibody Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Absolute Antibody Main Business Overview
11.12.5 Absolute Antibody Latest Developments
11.13 Alpalife (Shenzhen kangti Co., Ltd.)
11.13.1 Alpalife (Shenzhen kangti Co., Ltd.) Company Information
11.13.2 Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Product Offered
11.13.3 Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Alpalife (Shenzhen kangti Co., Ltd.) Main Business Overview
11.13.5 Alpalife (Shenzhen kangti Co., Ltd.) Latest Developments
11.14 DiosCURE Therapeutics SE
11.14.1 DiosCURE Therapeutics SE Company Information
11.14.2 DiosCURE Therapeutics SE Nano Antibodies Product Offered
11.14.3 DiosCURE Therapeutics SE Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 DiosCURE Therapeutics SE Main Business Overview
11.14.5 DiosCURE Therapeutics SE Latest Developments
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Information
11.15.2 Thermo Fisher Scientific Inc. Nano Antibodies Product Offered
11.15.3 Thermo Fisher Scientific Inc. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Thermo Fisher Scientific Inc. Main Business Overview
11.15.5 Thermo Fisher Scientific Inc. Latest Developments
11.16 PerkinElmer Inc. (BioLegend, Inc.)
11.16.1 PerkinElmer Inc. (BioLegend, Inc.) Company Information
11.16.2 PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Product Offered
11.16.3 PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 PerkinElmer Inc. (BioLegend, Inc.) Main Business Overview
11.16.5 PerkinElmer Inc. (BioLegend, Inc.) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nano Antibodies Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monovalent Nanobody
Table 3. Major Players of Multivalent and multispecific Nanobodies
Table 4. Major Players of Fusion Nanobody
Table 5. Nano Antibodies Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Nano Antibodies Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Nano Antibodies Market Size Market Share by Type (2019-2024)
Table 8. Nano Antibodies Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Nano Antibodies Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Nano Antibodies Market Size Market Share by Application (2019-2024)
Table 11. Global Nano Antibodies Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Nano Antibodies Revenue Market Share by Player (2019-2024)
Table 13. Nano Antibodies Key Players Head office and Products Offered
Table 14. Nano Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nano Antibodies Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Nano Antibodies Market Size Market Share by Regions (2019-2024)
Table 19. Global Nano Antibodies Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Nano Antibodies Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Nano Antibodies Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Nano Antibodies Market Size Market Share by Country (2019-2024)
Table 23. Americas Nano Antibodies Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Nano Antibodies Market Size Market Share by Type (2019-2024)
Table 25. Americas Nano Antibodies Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Nano Antibodies Market Size Market Share by Application (2019-2024)
Table 27. APAC Nano Antibodies Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Nano Antibodies Market Size Market Share by Region (2019-2024)
Table 29. APAC Nano Antibodies Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Nano Antibodies Market Size Market Share by Type (2019-2024)
Table 31. APAC Nano Antibodies Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Nano Antibodies Market Size Market Share by Application (2019-2024)
Table 33. Europe Nano Antibodies Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Nano Antibodies Market Size Market Share by Country (2019-2024)
Table 35. Europe Nano Antibodies Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Nano Antibodies Market Size Market Share by Type (2019-2024)
Table 37. Europe Nano Antibodies Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Nano Antibodies Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Nano Antibodies Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Nano Antibodies Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Nano Antibodies Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Nano Antibodies Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Nano Antibodies Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Nano Antibodies Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Nano Antibodies
Table 46. Key Market Challenges & Risks of Nano Antibodies
Table 47. Key Industry Trends of Nano Antibodies
Table 48. Global Nano Antibodies Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Nano Antibodies Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Nano Antibodies Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Nano Antibodies Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Merck KGaA Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 53. Merck KGaA Nano Antibodies Product Offered
Table 54. Merck KGaA Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Merck KGaA Main Business
Table 56. Merck KGaA Latest Developments
Table 57. Sanofi (Ablynx) Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 58. Sanofi (Ablynx) Nano Antibodies Product Offered
Table 59. Sanofi (Ablynx) Main Business
Table 60. Sanofi (Ablynx) Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Sanofi (Ablynx) Latest Developments
Table 62. Alphamab Oncology Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 63. Alphamab Oncology Nano Antibodies Product Offered
Table 64. Alphamab Oncology Main Business
Table 65. Alphamab Oncology Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Alphamab Oncology Latest Developments
Table 67. Novartis AG Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 68. Novartis AG Nano Antibodies Product Offered
Table 69. Novartis AG Main Business
Table 70. Novartis AG Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Novartis AG Latest Developments
Table 72. Genscript Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 73. Genscript Nano Antibodies Product Offered
Table 74. Genscript Main Business
Table 75. Genscript Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Genscript Latest Developments
Table 77. Taisho Pharmaceutical Holdings Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 78. Taisho Pharmaceutical Holdings Nano Antibodies Product Offered
Table 79. Taisho Pharmaceutical Holdings Main Business
Table 80. Taisho Pharmaceutical Holdings Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Taisho Pharmaceutical Holdings Latest Developments
Table 82. Sensei Biotherapeutics, Inc. Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 83. Sensei Biotherapeutics, Inc. Nano Antibodies Product Offered
Table 84. Sensei Biotherapeutics, Inc. Main Business
Table 85. Sensei Biotherapeutics, Inc. Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Sensei Biotherapeutics, Inc. Latest Developments
Table 87. Cusabio Technology LLC. Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 88. Cusabio Technology LLC. Nano Antibodies Product Offered
Table 89. Cusabio Technology LLC. Main Business
Table 90. Cusabio Technology LLC. Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Cusabio Technology LLC. Latest Developments
Table 92. ChromoTek GmbH Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 93. ChromoTek GmbH Nano Antibodies Product Offered
Table 94. ChromoTek GmbH Main Business
Table 95. ChromoTek GmbH Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. ChromoTek GmbH Latest Developments
Table 97. Beroni Group Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 98. Beroni Group Nano Antibodies Product Offered
Table 99. Beroni Group Main Business
Table 100. Beroni Group Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Beroni Group Latest Developments
Table 102. ExeVir Bio BV Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 103. ExeVir Bio BV Nano Antibodies Product Offered
Table 104. ExeVir Bio BV Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. ExeVir Bio BV Main Business
Table 106. ExeVir Bio BV Latest Developments
Table 107. Absolute Antibody Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 108. Absolute Antibody Nano Antibodies Product Offered
Table 109. Absolute Antibody Main Business
Table 110. Absolute Antibody Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Absolute Antibody Latest Developments
Table 112. Alpalife (Shenzhen kangti Co., Ltd.) Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 113. Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Product Offered
Table 114. Alpalife (Shenzhen kangti Co., Ltd.) Main Business
Table 115. Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Alpalife (Shenzhen kangti Co., Ltd.) Latest Developments
Table 117. DiosCURE Therapeutics SE Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 118. DiosCURE Therapeutics SE Nano Antibodies Product Offered
Table 119. DiosCURE Therapeutics SE Main Business
Table 120. DiosCURE Therapeutics SE Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. DiosCURE Therapeutics SE Latest Developments
Table 122. Thermo Fisher Scientific Inc. Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 123. Thermo Fisher Scientific Inc. Nano Antibodies Product Offered
Table 124. Thermo Fisher Scientific Inc. Main Business
Table 125. Thermo Fisher Scientific Inc. Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Thermo Fisher Scientific Inc. Latest Developments
Table 127. PerkinElmer Inc. (BioLegend, Inc.) Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 128. PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Product Offered
Table 129. PerkinElmer Inc. (BioLegend, Inc.) Main Business
Table 130. PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. PerkinElmer Inc. (BioLegend, Inc.) Latest Developments
Table 1. Nano Antibodies Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monovalent Nanobody
Table 3. Major Players of Multivalent and multispecific Nanobodies
Table 4. Major Players of Fusion Nanobody
Table 5. Nano Antibodies Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Nano Antibodies Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Nano Antibodies Market Size Market Share by Type (2019-2024)
Table 8. Nano Antibodies Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Nano Antibodies Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Nano Antibodies Market Size Market Share by Application (2019-2024)
Table 11. Global Nano Antibodies Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Nano Antibodies Revenue Market Share by Player (2019-2024)
Table 13. Nano Antibodies Key Players Head office and Products Offered
Table 14. Nano Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nano Antibodies Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Nano Antibodies Market Size Market Share by Regions (2019-2024)
Table 19. Global Nano Antibodies Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Nano Antibodies Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Nano Antibodies Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Nano Antibodies Market Size Market Share by Country (2019-2024)
Table 23. Americas Nano Antibodies Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Nano Antibodies Market Size Market Share by Type (2019-2024)
Table 25. Americas Nano Antibodies Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Nano Antibodies Market Size Market Share by Application (2019-2024)
Table 27. APAC Nano Antibodies Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Nano Antibodies Market Size Market Share by Region (2019-2024)
Table 29. APAC Nano Antibodies Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Nano Antibodies Market Size Market Share by Type (2019-2024)
Table 31. APAC Nano Antibodies Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Nano Antibodies Market Size Market Share by Application (2019-2024)
Table 33. Europe Nano Antibodies Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Nano Antibodies Market Size Market Share by Country (2019-2024)
Table 35. Europe Nano Antibodies Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Nano Antibodies Market Size Market Share by Type (2019-2024)
Table 37. Europe Nano Antibodies Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Nano Antibodies Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Nano Antibodies Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Nano Antibodies Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Nano Antibodies Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Nano Antibodies Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Nano Antibodies Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Nano Antibodies Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Nano Antibodies
Table 46. Key Market Challenges & Risks of Nano Antibodies
Table 47. Key Industry Trends of Nano Antibodies
Table 48. Global Nano Antibodies Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Nano Antibodies Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Nano Antibodies Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Nano Antibodies Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Merck KGaA Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 53. Merck KGaA Nano Antibodies Product Offered
Table 54. Merck KGaA Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Merck KGaA Main Business
Table 56. Merck KGaA Latest Developments
Table 57. Sanofi (Ablynx) Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 58. Sanofi (Ablynx) Nano Antibodies Product Offered
Table 59. Sanofi (Ablynx) Main Business
Table 60. Sanofi (Ablynx) Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Sanofi (Ablynx) Latest Developments
Table 62. Alphamab Oncology Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 63. Alphamab Oncology Nano Antibodies Product Offered
Table 64. Alphamab Oncology Main Business
Table 65. Alphamab Oncology Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Alphamab Oncology Latest Developments
Table 67. Novartis AG Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 68. Novartis AG Nano Antibodies Product Offered
Table 69. Novartis AG Main Business
Table 70. Novartis AG Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Novartis AG Latest Developments
Table 72. Genscript Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 73. Genscript Nano Antibodies Product Offered
Table 74. Genscript Main Business
Table 75. Genscript Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Genscript Latest Developments
Table 77. Taisho Pharmaceutical Holdings Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 78. Taisho Pharmaceutical Holdings Nano Antibodies Product Offered
Table 79. Taisho Pharmaceutical Holdings Main Business
Table 80. Taisho Pharmaceutical Holdings Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Taisho Pharmaceutical Holdings Latest Developments
Table 82. Sensei Biotherapeutics, Inc. Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 83. Sensei Biotherapeutics, Inc. Nano Antibodies Product Offered
Table 84. Sensei Biotherapeutics, Inc. Main Business
Table 85. Sensei Biotherapeutics, Inc. Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Sensei Biotherapeutics, Inc. Latest Developments
Table 87. Cusabio Technology LLC. Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 88. Cusabio Technology LLC. Nano Antibodies Product Offered
Table 89. Cusabio Technology LLC. Main Business
Table 90. Cusabio Technology LLC. Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Cusabio Technology LLC. Latest Developments
Table 92. ChromoTek GmbH Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 93. ChromoTek GmbH Nano Antibodies Product Offered
Table 94. ChromoTek GmbH Main Business
Table 95. ChromoTek GmbH Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. ChromoTek GmbH Latest Developments
Table 97. Beroni Group Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 98. Beroni Group Nano Antibodies Product Offered
Table 99. Beroni Group Main Business
Table 100. Beroni Group Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Beroni Group Latest Developments
Table 102. ExeVir Bio BV Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 103. ExeVir Bio BV Nano Antibodies Product Offered
Table 104. ExeVir Bio BV Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. ExeVir Bio BV Main Business
Table 106. ExeVir Bio BV Latest Developments
Table 107. Absolute Antibody Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 108. Absolute Antibody Nano Antibodies Product Offered
Table 109. Absolute Antibody Main Business
Table 110. Absolute Antibody Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Absolute Antibody Latest Developments
Table 112. Alpalife (Shenzhen kangti Co., Ltd.) Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 113. Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Product Offered
Table 114. Alpalife (Shenzhen kangti Co., Ltd.) Main Business
Table 115. Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Alpalife (Shenzhen kangti Co., Ltd.) Latest Developments
Table 117. DiosCURE Therapeutics SE Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 118. DiosCURE Therapeutics SE Nano Antibodies Product Offered
Table 119. DiosCURE Therapeutics SE Main Business
Table 120. DiosCURE Therapeutics SE Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. DiosCURE Therapeutics SE Latest Developments
Table 122. Thermo Fisher Scientific Inc. Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 123. Thermo Fisher Scientific Inc. Nano Antibodies Product Offered
Table 124. Thermo Fisher Scientific Inc. Main Business
Table 125. Thermo Fisher Scientific Inc. Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Thermo Fisher Scientific Inc. Latest Developments
Table 127. PerkinElmer Inc. (BioLegend, Inc.) Details, Company Type, Nano Antibodies Area Served and Its Competitors
Table 128. PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Product Offered
Table 129. PerkinElmer Inc. (BioLegend, Inc.) Main Business
Table 130. PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. PerkinElmer Inc. (BioLegend, Inc.) Latest Developments
LIST OF FIGURES
Figure 1. Nano Antibodies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nano Antibodies Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Nano Antibodies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nano Antibodies Sales Market Share by Country/Region (2023)
Figure 8. Nano Antibodies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nano Antibodies Market Size Market Share by Type in 2023
Figure 10. Nano Antibodies in Disease detection in vitro
Figure 11. Global Nano Antibodies Market: Disease detection in vitro (2019-2024) & ($ Millions)
Figure 12. Nano Antibodies in Non-invasive diagnosis in vivo
Figure 13. Global Nano Antibodies Market: Non-invasive diagnosis in vivo (2019-2024) & ($ Millions)
Figure 14. Nano Antibodies in Tumor targeted therapy
Figure 15. Global Nano Antibodies Market: Tumor targeted therapy (2019-2024) & ($ Millions)
Figure 16. Nano Antibodies in Nervous system disease
Figure 17. Global Nano Antibodies Market: Nervous system disease (2019-2024) & ($ Millions)
Figure 18. Nano Antibodies in Circulatory disease
Figure 19. Global Nano Antibodies Market: Circulatory disease (2019-2024) & ($ Millions)
Figure 20. Nano Antibodies in Infectious disease
Figure 21. Global Nano Antibodies Market: Infectious disease (2019-2024) & ($ Millions)
Figure 22. Nano Antibodies in Other
Figure 23. Global Nano Antibodies Market: Other (2019-2024) & ($ Millions)
Figure 24. Global Nano Antibodies Market Size Market Share by Application in 2023
Figure 25. Global Nano Antibodies Revenue Market Share by Player in 2023
Figure 26. Global Nano Antibodies Market Size Market Share by Regions (2019-2024)
Figure 27. Americas Nano Antibodies Market Size 2019-2024 ($ Millions)
Figure 28. APAC Nano Antibodies Market Size 2019-2024 ($ Millions)
Figure 29. Europe Nano Antibodies Market Size 2019-2024 ($ Millions)
Figure 30. Middle East & Africa Nano Antibodies Market Size 2019-2024 ($ Millions)
Figure 31. Americas Nano Antibodies Value Market Share by Country in 2023
Figure 32. United States Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 33. Canada Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 34. Mexico Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 35. Brazil Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 36. APAC Nano Antibodies Market Size Market Share by Region in 2023
Figure 37. APAC Nano Antibodies Market Size Market Share by Type in 2023
Figure 38. APAC Nano Antibodies Market Size Market Share by Application in 2023
Figure 39. China Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 40. Japan Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 41. Korea Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 42. Southeast Asia Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 43. India Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 44. Australia Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 45. Europe Nano Antibodies Market Size Market Share by Country in 2023
Figure 46. Europe Nano Antibodies Market Size Market Share by Type (2019-2024)
Figure 47. Europe Nano Antibodies Market Size Market Share by Application (2019-2024)
Figure 48. Germany Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 49. France Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 50. UK Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 51. Italy Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 52. Russia Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 53. Middle East & Africa Nano Antibodies Market Size Market Share by Region (2019-2024)
Figure 54. Middle East & Africa Nano Antibodies Market Size Market Share by Type (2019-2024)
Figure 55. Middle East & Africa Nano Antibodies Market Size Market Share by Application (2019-2024)
Figure 56. Egypt Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 57. South Africa Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 58. Israel Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 59. Turkey Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 60. GCC Country Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 61. Americas Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 62. APAC Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 63. Europe Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 64. Middle East & Africa Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 65. United States Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 66. Canada Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 67. Mexico Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 68. Brazil Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 69. China Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 70. Japan Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 71. Korea Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 72. Southeast Asia Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 73. India Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 74. Australia Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 75. Germany Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 76. France Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 77. UK Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 78. Italy Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 79. Russia Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 80. Spain Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 81. Egypt Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 82. South Africa Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 83. Israel Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 84. Turkey Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 85. GCC Countries Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 86. Global Nano Antibodies Market Size Market Share Forecast by Type (2025-2030)
Figure 87. Global Nano Antibodies Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Nano Antibodies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nano Antibodies Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Nano Antibodies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nano Antibodies Sales Market Share by Country/Region (2023)
Figure 8. Nano Antibodies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nano Antibodies Market Size Market Share by Type in 2023
Figure 10. Nano Antibodies in Disease detection in vitro
Figure 11. Global Nano Antibodies Market: Disease detection in vitro (2019-2024) & ($ Millions)
Figure 12. Nano Antibodies in Non-invasive diagnosis in vivo
Figure 13. Global Nano Antibodies Market: Non-invasive diagnosis in vivo (2019-2024) & ($ Millions)
Figure 14. Nano Antibodies in Tumor targeted therapy
Figure 15. Global Nano Antibodies Market: Tumor targeted therapy (2019-2024) & ($ Millions)
Figure 16. Nano Antibodies in Nervous system disease
Figure 17. Global Nano Antibodies Market: Nervous system disease (2019-2024) & ($ Millions)
Figure 18. Nano Antibodies in Circulatory disease
Figure 19. Global Nano Antibodies Market: Circulatory disease (2019-2024) & ($ Millions)
Figure 20. Nano Antibodies in Infectious disease
Figure 21. Global Nano Antibodies Market: Infectious disease (2019-2024) & ($ Millions)
Figure 22. Nano Antibodies in Other
Figure 23. Global Nano Antibodies Market: Other (2019-2024) & ($ Millions)
Figure 24. Global Nano Antibodies Market Size Market Share by Application in 2023
Figure 25. Global Nano Antibodies Revenue Market Share by Player in 2023
Figure 26. Global Nano Antibodies Market Size Market Share by Regions (2019-2024)
Figure 27. Americas Nano Antibodies Market Size 2019-2024 ($ Millions)
Figure 28. APAC Nano Antibodies Market Size 2019-2024 ($ Millions)
Figure 29. Europe Nano Antibodies Market Size 2019-2024 ($ Millions)
Figure 30. Middle East & Africa Nano Antibodies Market Size 2019-2024 ($ Millions)
Figure 31. Americas Nano Antibodies Value Market Share by Country in 2023
Figure 32. United States Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 33. Canada Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 34. Mexico Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 35. Brazil Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 36. APAC Nano Antibodies Market Size Market Share by Region in 2023
Figure 37. APAC Nano Antibodies Market Size Market Share by Type in 2023
Figure 38. APAC Nano Antibodies Market Size Market Share by Application in 2023
Figure 39. China Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 40. Japan Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 41. Korea Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 42. Southeast Asia Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 43. India Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 44. Australia Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 45. Europe Nano Antibodies Market Size Market Share by Country in 2023
Figure 46. Europe Nano Antibodies Market Size Market Share by Type (2019-2024)
Figure 47. Europe Nano Antibodies Market Size Market Share by Application (2019-2024)
Figure 48. Germany Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 49. France Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 50. UK Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 51. Italy Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 52. Russia Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 53. Middle East & Africa Nano Antibodies Market Size Market Share by Region (2019-2024)
Figure 54. Middle East & Africa Nano Antibodies Market Size Market Share by Type (2019-2024)
Figure 55. Middle East & Africa Nano Antibodies Market Size Market Share by Application (2019-2024)
Figure 56. Egypt Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 57. South Africa Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 58. Israel Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 59. Turkey Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 60. GCC Country Nano Antibodies Market Size Growth 2019-2024 ($ Millions)
Figure 61. Americas Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 62. APAC Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 63. Europe Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 64. Middle East & Africa Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 65. United States Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 66. Canada Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 67. Mexico Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 68. Brazil Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 69. China Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 70. Japan Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 71. Korea Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 72. Southeast Asia Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 73. India Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 74. Australia Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 75. Germany Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 76. France Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 77. UK Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 78. Italy Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 79. Russia Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 80. Spain Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 81. Egypt Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 82. South Africa Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 83. Israel Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 84. Turkey Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 85. GCC Countries Nano Antibodies Market Size 2025-2030 ($ Millions)
Figure 86. Global Nano Antibodies Market Size Market Share Forecast by Type (2025-2030)
Figure 87. Global Nano Antibodies Market Size Market Share Forecast by Application (2025-2030)
